Dan A Dixon
9PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jul 02, 2025
The XPO1 Inhibitor Eltanexor Modulates the Wnt/β-Catenin Signaling Pathway to Reduce Colorectal Cancer Tumorigenesis.Andrew E Evans, Sahida Afroz, Alexa Magstadt
|Jul 26, 2024
Plasma-Derived Extracellular Vesicles and Non-Extracellular Vesicle Components from APCMin/+ Mice Promote Pro-Tumorigenic Activities and Activate Human Colonic Fibroblasts via the NF-κB Signaling Pathway.Luis A Arteaga-Blanco, Andrew E Evans, Dan A Dixon
|Sep 08, 2023
Targeting the RNA-Binding Protein HuR in Cancer.Jennifer M Finan, Thomas L Sutton, Dan A Dixon
|Jun 15, 2022
The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma.Samantha Z Brown, Grace A McCarthy, James R Carroll
|Aug 20, 2021
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria.Christopher W Schultz, Grace A McCarthy, Teena Nerwal
|Sep 04, 2020
An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells.Ruochen Dong, Ping Chen, Kishore Polireddy
Pageof 2
Frequent Collaborators
3 joint publications
Jonathan R Brody
2 joint publications
Andrew E Evans
2 joint publications
Samantha Z Brown
2 joint publications
Jeffrey Aubé
1 joint publications
Xiaoqing Wu
1 joint publications
Gulhumay Gardashova
1 joint publications
Anup Kasi
1 joint publications
Cuncong Zhong
1 joint publications
Sudeshna Roy
1 joint publications
John Karanicolas
